Lawrence J. Jasinski - 07 May 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 May 2026, 17:08:31 UTC
Prior SEC filing
30 Mar 2026
Next SEC filing
05 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

Lawrence J. Jasinski filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 11 May 2026.

Key facts

  • This page summarizes Lawrence J. Jasinski's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
  • 7 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 11 May 2026, 17:08.

Change

  • Previous filing in this sequence was filed on 30 Mar 2026.
  • Current net transaction value: -$433,730.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001366346 Primary reporting owner

Jasinski Lawrence J

Relationship
Director
Address
C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Signature date
11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LMAT transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,069
Change %
+18%
Price
$47.19*
Shares after
6,868
Date
07 May 2026
Ownership
Direct
Footnotes
F1
LMAT transaction

Common Stock

Options Exercise

Transaction value
Shares
+924
Change %
+13%
Price
$54.65*
Shares after
7,792
Date
07 May 2026
Ownership
Direct
Footnotes
F1
LMAT transaction

Common Stock

Options Exercise

Transaction value
Shares
+865
Change %
+11%
Price
$101.12*
Shares after
8,657
Date
07 May 2026
Ownership
Direct
Footnotes
F1
LMAT transaction

Common Stock

Sale

Transaction value
$433,730
Shares
-3,943
Change %
-46%
Price
$110.00
Shares after
4,714
Date
07 May 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-1,069
Change %
-33%
Price
$0.000000*
Shares after
2,140
Date
07 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,069
Exercise price
$47.19
Footnotes
F2
LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-924
Change %
-33%
Price
$0.000000*
Shares after
1,848
Date
07 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
924
Exercise price
$54.65
Footnotes
F3
LMAT transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-865
Change %
-33%
Price
$0.000000*
Shares after
1,729
Date
07 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
865
Exercise price
$101.12
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

Footnote F2

This option is fully vested and exercisable.

Footnote F3

This option is exercisable and vests over a three-year period at a rate of 33.3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .